Showing results (851-860 of 1,196) with videos related to

Sort By:
Pageof 120
JACC. Heart Failure|March 2, 2019
Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT TrialMiranda Merrill, Nancy K Sweitzer, JoAnn Lindenfeld, et al.
JACC. Heart Failure|May 13, 2019
Ambulatory Advanced Heart Failure in Women: A Report From the REVIVAL RegistryGarrick C Stewart, Thomas Cascino, Blair Richards, et al.
JACC. Heart Failure|July 13, 2020
Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart FailureJadry Gruen, Cesar Caraballo, P Elliott Miller, et al.
JACC. Heart Failure|July 2, 2026
Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients: An Analysis From the EMPEROR-Reduced TrialMehmet K Aktaş, Khawaja M Talha, Ilan Goldenberg, et al.
JACC. Heart Failure|June 30, 2026
Endomyocardial Biopsy-Based Inflammatory Phenotypes Predict Outcomes in Virus-Negative Dilated and Inflammatory CardiomyopathyChristian Baumeier, Felicitas Escher, Ganna Aleshcheva, et al.
JACC. Heart Failure|March 14, 2014
Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)Jeffrey J Teuteberg, Garrick C Stewart, Mariell Jessup, et al.
JACC. Heart Failure|June 26, 2026
Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure CollaboratoryVanessa Blumer, Janet T Wittes, Jordan E Pomeroy, et al.
JACC. Heart Failure|June 3, 2026
Screening and Treatment Using a Risk-Based Approach with NT-proBNP Guidance in Diabetes Mellitus: The STRONG-DM Pilot StudyVinayak Subramanian, Kershaw V Patel, Jude Moutchia Suh, et al.
JACC. Heart Failure|June 2, 2026
Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position StatementShannon M Dunlay, Monica Colvin, Jennifer A Cowger, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
Pageof 120